Upper-Limb Disability and the Severity of Lymphedema Reduce the Quality of Life of Patients with Breast Cancer-Related Lymphedema
Metadatos
Mostrar el registro completo del ítemEditorial
MDPI
Materia
Breast Neoplasms Disability evaluation Breast cancer-related lymphedema
Fecha
2023-08-31Referencia bibliográfica
Ramirez-Parada, K.; Gonzalez-Santos, A.; Riady-Aleuy, L.; Pinto, M.P.; Ibañez, C.; Merino, T.; Acevedo, F.;Walbaum, B.; Fernández-Verdejo, R.; Sanchez, C. Upper-Limb Disability and the Severity of Lymphedema Reduce the Quality of Life of Patients with Breast Cancer-Related Lymphedema. Curr. Oncol. 2023, 30, 8068–8077. [https://doi.org/10.3390/curroncol30090585]
Resumen
Breast cancer-related lymphedema (BCRL) is characterized by arm swelling, pain, and
discomfort, reducing the quality of life (QoL) of affected individuals. BRCL is caused via the blockage
or disruption of the lymphatic vessels following cancer treatments, leading to an accumulation of
fluid in the affected arm. While current BCRL rehabilitation treatments seek to reduce arm swelling,
our study aimed to examine the impact of both the magnitude of lymphedema (DVolume) and arm
disability on three dimensions of QoL: social, physical, and psychological. Using the Disabilities of the
Arm, Shoulder, and Hand questionnaire (DASH) and the Upper Limb Lymphedema 27 questionnaire
(ULL) in a group of 30 patients, we found that the magnitude of lymphedema (DVolume) was
associated with the social dimension of QoL (r = 0.37, p = 0.041), but not with other dimensions.
On the other hand, arm disability was associated with all evaluated dimensions of QoL (social,
physical, and psychological: p < 0.001, p = 0.019, and p = 0.050 (borderline), respectively). These
findings suggest that BCRL rehabilitation strategies should not only aim to reduce the magnitude of
lymphedema but should also seek to improve or preserve arm functionality to enhance the QoL of
BCRL patients.